2007
DOI: 10.1111/j.1524-6175.2007.06296.x
|View full text |Cite
|
Sign up to set email alerts
|

Antihypertensive Medications and Anemia

Abstract: Antihypertensive medication use can be associated with a reduction in hemoglobin concentration. The magnitude of such a change is generally small, but in certain instances it can be extreme enough to produce a clinically significant degree of anemia. The mechanistic basis for antihypertensive medication-related changes in hemoglobin concentration include hemodilution, hemolytic anemia, and suppression of red blood cell production, as this occurs most commonly with angiotensin-converting enzyme inhibitors and a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
11
0
7

Year Published

2008
2008
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(23 citation statements)
references
References 53 publications
3
11
0
7
Order By: Relevance
“…In men, current use of anti-hypertensives and antidiabetics/insulin were negatively related to hemoglobin values. This was also consistent with previous reports [27,28]. Some types of antihypertensives cause hemodilution, hemolytic anemia, or suppress red cell production [27].…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…In men, current use of anti-hypertensives and antidiabetics/insulin were negatively related to hemoglobin values. This was also consistent with previous reports [27,28]. Some types of antihypertensives cause hemodilution, hemolytic anemia, or suppress red cell production [27].…”
Section: Discussionsupporting
confidence: 82%
“…This was also consistent with previous reports [27,28]. Some types of antihypertensives cause hemodilution, hemolytic anemia, or suppress red cell production [27]. Long term metformin treatment for diabetes suppresses absorption of vitamin B 12 , and may lead to anemia [28].…”
Section: Discussionsupporting
confidence: 80%
“…Angiotensin II, a component of the regulatory pathway initiated by renin, acts directly as a growth factor through the AT1 receptor, stimulating proliferation of erythroid progenitors in bone marrow and, additionally, it enhances erythropoietin secretion (Vlahakos et al, 2010). This mechanism also explains anaemia that has been described as a side effect of drugs interfering with the renin-angiotensin system (Sica and Mannino, 2007).…”
Section: Blood Rheology and The Pathophysiology Of Hypertensionmentioning
confidence: 99%
“…Overt clinical anemia is not a common side effect of methyldopa; it affects only some 1-5% of treated patients [8] . Accelerated eryptosis may be compensated by en- Fig.…”
Section: +mentioning
confidence: 99%
“…Side effects of methyldopa include hemolytic anemia [5][6][7] , which could affect 1-5% of patients [8] . In other conditions with hemolytic anemia, such as iron deficiency [9] , hemolytic uremic syndrome [10] and sepsis [11] , the accelerated clearance of circulating erythrocytes results at least in part from enhanced eryptosis, the suicidal death of erythrocytes [12] .…”
Section: Introductionmentioning
confidence: 99%